HomeCompareMDNA vs GIS

MDNA vs GIS: Dividend Comparison 2026

MDNA yields 1273.89% · GIS yields 6.53%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDNA wins by $160323633.68M in total portfolio value
10 years
MDNA
MDNA
● Live price
1273.89%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$160323633.76M
Annual income
$138,877,914,359,413.77
Full MDNA calculator →
GIS
GIS
● Live price
6.53%
Share price
$37.22
Annual div
$2.43
5Y div CAGR
22.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.8K
Annual income
$16,211.26
Full GIS calculator →

Portfolio growth — MDNA vs GIS

📍 MDNA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDNAGIS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDNA + GIS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDNA pays
GIS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDNA
Annual income on $10K today (after 15% tax)
$108,280.25/yr
After 10yr DRIP, annual income (after tax)
$118,046,227,205,501.70/yr
GIS
Annual income on $10K today (after 15% tax)
$554.94/yr
After 10yr DRIP, annual income (after tax)
$13,779.57/yr
At 15% tax rate, MDNA beats the other by $118,046,227,191,722.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDNA + GIS for your $10,000?

MDNA: 50%GIS: 50%
100% GIS50/50100% MDNA
Portfolio after 10yr
$80161816.92M
Annual income
$69,438,957,187,812.52/yr
Blended yield
86.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GIS right now

MDNA
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-4.1
Piotroski
1/9
GIS
Analyst Ratings
9
Buy
19
Hold
6
Sell
Consensus: Hold
Price Target
$47.42
+27.4% upside vs current
Range: $35.00 — $63.00
Altman Z
2.2
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDNA buys
0
GIS buys
0
No recent congressional trades found for MDNA or GIS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDNAGIS
Forward yield1273.89%6.53%
Annual dividend / share$2.00$2.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.8%
Portfolio after 10y$160323633.76M$78.8K
Annual income after 10y$138,877,914,359,413.77$16,211.26
Total dividends collected$158734778.42M$50.8K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: MDNA vs GIS ($10,000, DRIP)

YearMDNA PortfolioMDNA Income/yrGIS PortfolioGIS Income/yrGap
1← crossover$138,089$127,388.54$11,502$801.73+$126.6KMDNA
2$1,791,764$1,644,008.99$13,365$1,058.29+$1.78MMDNA
3$21,853,440$19,936,252.56$15,712$1,411.34+$21.84MMDNA
4$250,630,524$227,247,343.53$18,716$1,904.17+$250.61MMDNA
5$2,703,904,938$2,435,730,277.70$22,629$2,603.16+$2703.88MMDNA
6$27,451,736,905$24,558,558,620.99$27,826$3,612.21+$27451.71MMDNA
7$262,395,669,533$233,022,311,044.44$34,871$5,097.54+$262395.63MMDNA
8$2,362,379,104,913$2,081,615,738,512.96$44,643$7,331.52+$2362379.06MMDNA
9$20,042,728,412,877$17,514,982,770,620.17$58,541$10,772.15+$20042728.35MMDNA
10$160,323,633,761,192$138,877,914,359,413.77$78,850$16,211.26+$160323633.68MMDNA

MDNA vs GIS: Complete Analysis 2026

MDNAStock

Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.

Full MDNA Calculator →

GISConsumer Staples

General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates in five segments: North America Retail; Convenience Stores & Foodservice; Europe & Australia; Asia & Latin America; and Pet. It offers ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, bakery flour, frozen pizza and pizza snacks, snack bars, fruit and salty snacks, ice cream, nutrition bars, wellness beverages, and savory and grain snacks, as well as various organic products, including frozen and shelf-stable vegetables. It also supplies branded and unbranded food products to the North American foodservice and commercial baking industries; and manufactures and markets pet food products, including dog and cat food. The company markets its products under the Annie's, Betty Crocker, Bisquick, Blue Buffalo, Blue Basics, Blue Freedom, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, EPIC, Fiber One, Food Should Taste Good, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto's, Go-Gurt, Gold Medal, Golden Grahams, Häagen-Dazs, Helpers, Jus-Rol, Kitano, Kix, Lärabar, Latina, Liberté, Lucky Charms, Muir Glen, Nature Valley, Oatmeal Crisp, Old El Paso, Oui, Pillsbury, Progresso, Raisin Nut Bran, Total, Totino's, Trix, Wanchai Ferry, Wheaties, Wilderness, Yoki, and Yoplait trademarks. It sells its products directly, as well as through broker and distribution arrangements to grocery stores, mass merchandisers, membership stores, natural food chains, e-commerce retailers, commercial and noncommercial foodservice distributors and operators, restaurants, convenience stores, and pet specialty stores, as well as drug, dollar, and discount chains. The company operates 466 leased and 392 franchise ice cream parlors. General Mills, Inc. was founded in 1866 and is headquartered in Minneapolis, Minnesota.

Full GIS Calculator →
📬

Get this MDNA vs GIS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDNA vs SCHDMDNA vs JEPIMDNA vs OMDNA vs KOMDNA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.